Early Clinical Studies of Novel Therapies for Thyroid Cancers
- 1 June 2008
- journal article
- research article
- Published by Elsevier BV in Endocrinology and Metabolism Clinics of North America
- Vol. 37 (2), 511-524
- https://doi.org/10.1016/j.ecl.2008.02.005
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines TaskforceThyroid®, 2006
- Angiogenesis as a therapeutic targetNature, 2005
- How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapyJournal of Endocrinology, 2004
- Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancerSurgery, 2001
- Increased Expression of the Vascular Endothelial Growth Factor Is a Pejorative Prognosis Marker in Papillary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2001
- Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour InfusionThyroid®, 2000
- Mechanisms of angiogenesis and arteriogenesisNature Medicine, 2000
- Management of the patient with progressive radioiodine non-responsive diseaseSeminars in Surgical Oncology, 1999
- A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinomaCancer, 1985
- Chemotherapy of Thyroid Cancer with AdriamycinThe New England Journal of Medicine, 1974